Pharma Capital
Showing 40 of 58
Name Market Market Cap Share Price Daily Share Movement
abzena-logo.png Abzena plc AIM £110.02m £0.52 0.00% ico_glass.png
ahz[LOGO]200x100.jpg Admedus Ltd ASX £43.45m £0.17 -1.75% ico_glass.png
Advanced-Oncotherapy-logo.png Advanced Oncotherapy AIM £12.95m £0.16 -3.03% ico_glass.png
akers.png Akers Biosciences, Inc. AIM £8.90m £1.00 0.00% ico_glass.png
allergytherap.gif Allergy Therapeutics plc AIM £184.18m £0.31 1.22% ico_glass.png
Alliance-logo.png Alliance Pharma plc AIM £252.57m £0.53 3.40% ico_glass.png
Amryt_Pharma_59677939c44cb.png Amryt Pharmaceuticals AIM £45.31m £0.22 0.00% ico_glass.png
angle-logo.png ANGLE plc AIM £40.03m £0.54 -0.93% ico_glass.png
avacta.png Avacta Group Plc AIM £58.82m £0.86 -0.58% ico_glass.png
c4x.png C4X Discovery Holdings plc AIM £40.97m £0.88 0.00% ico_glass.png
cdy[LOGO]200x100.jpg Cellmid Ltd ASX £17.64m £0.02 4.00% ico_glass.png
clinigen-logo.png Clinigen Group PLC AIM £1,113.55m £9.67 2.98% ico_glass.png
collagen_solutions.png Collagen Solutions PLC AIM £16.24m £0.05 0.00% ico_glass.png
concepta.png Concepta AIM £13.02m £0.12 0.00% ico_glass.png
Cynata.png Cynata Therapeutics ASX £33.18m £0.37 1.68% ico_glass.png
deltex-logo.png Deltex Medical Group plc AIM £10.76m £0.04 -3.33% ico_glass.png
e-ther.png e-Therapeutics plc AIM £32.55m £0.12 0.00% ico_glass.png
Ergomed-logo.png Ergomed Plc AIM £78.15m £1.93 0.00% ico_glass.png
fr.png Faron Pharmaceuticals Oy AIM £199.59m £7.15 0.00% ico_glass.png
FuturaMedical-Logo-1row-RGB.jpg Futura Medical plc. AIM £66.36m £0.55 -0.90% ico_glass.png
genedrive_logo.png Genedrive PLC AIM £7.94m £0.43 0.00% ico_glass.png
Horizon-logo.2.png Horizon Discovery Group PLC AIM £250.12m £2.59 -4.60% ico_glass.png
imm.gif ImmuPharma PLC AIM £75.54m £0.57 0.00% ico_glass.png
ID_LOGO.png InnovaDerma LSE £41.17m £3.28 -4.38% ico_glass.png
ixico-logo.png IXICO Plc AIM £8.68m £0.32 0.00% ico_glass.png
m_pharma_5739c0416b400.png M Pharmaceutical CSE £7.34m £0.03 0.00% ico_glass.png
MaxCyte.gif MaxCyte AIM £124.55m £2.45 1.03% ico_glass.png
Midatech_pharma.png Midatech Pharma Plc AIM £49.92m £1.03 0.00% ico_glass.png
motif-bio-logo-2.png Motif Bio Plc AIM £56.81m £0.29 2.20% ico_glass.png
nanobiotix_logo.png Nanobiotix SA EPA £- £- - ico_glass.png
netscientific-logo.png Netscientific PLC AIM £32.10m £0.47 0.00% ico_glass.png
au_novogen__120x60.jpg Novogen ASX £11.48m £0.02 -2.50% ico_glass.png
optibiotix-logo-2.png OptiBiotix Health plc AIM £52.62m £0.67 3.08% ico_glass.png
par[LOGO]200x100.jpg Paradigm Biopharmaceuticals Ltd ASX £16.45m £0.16 -1.85% ico_glass.png
Pharmaxis---200x100.jpg Pharmaxis Ltd ASX £48.62m £0.15 -1.96% ico_glass.png
pbi120.jpg Pressure Biosciences Inc OTCMKTS £- £- - ico_glass.png
au_piqlogo_new120x60.jpg Proteomics International Laboratories ASX £7.19m £0.12 -4.76% ico_glass.png
qbio.png Q BioMed Inc OTCMKTS £- £- - ico_glass.png
redx-logo.png Redx Pharma Plc AIM £40.95m £0.32 -1.52% ico_glass.png
rgs[LOGO]200x100.jpg Regeneus Ltd ASX £14.63m £0.07 -4.17% ico_glass.png

© biotech Capital 2017

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.